Return to play in the athlete with cardiac disease: who decides and what is the protocol?

Michael J Silka1

  • 1Division of Cardiology,Children's Hospital Los Angeles,Keck School of Medicine,University of Southern California,Los Angeles,California,United States of America.

Cardiology in the Young
|January 14, 2017
PubMed

Insights

Developing return-to-play protocols for athletes with treated cardiovascular abnormalities is challenging due to limited data. This review examines ethical considerations and current practices for these athletes.

Area of Science:

  • Sports Medicine
  • Cardiology
  • Medical Ethics

Background:

  • Established return-to-play (RTP) protocols exist for concussion and orthopedic injuries.
  • Criteria for disqualification/eligibility for athletes with congenital cardiovascular abnormalities are developing.
  • Lack of specific RTP data for treated cardiovascular conditions complicates decision-making.

Purpose of the Study:

  • To review current data and practices for RTP decisions in athletes with treated cardiovascular abnormalities.
  • To discuss the ethical dilemmas faced by team physicians in RTP decisions.
  • To highlight the role of cardiovascular consultants in managing these athletes.

Main Methods:

  • Literature review of current data and practices.
  • Discussion of ethical considerations for team physicians.
  • Analysis of RTP recommendations for specific cardiovascular conditions.

Main Results:

  • Inadequate data exists for developing specific RTP protocols for treated cardiovascular abnormalities.
  • Team physicians face ethical conflicts between team goals and individual athlete welfare.
  • Current RTP practices for conditions like supraventricular tachycardia ablation, device implantation, syncope, and genetic mutations are discussed.

Conclusions:

  • Specific RTP protocols for treated cardiovascular abnormalities are needed.
  • Clearer guidelines and collaboration between team physicians and cardiovascular consultants are essential.
  • Recommendations provided serve as a starting point for evolving RTP decision-making.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
2.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
282
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689